HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$1.68
Day range
$1.57 - $1.74
Year range
$1.26 - $2.73
Market cap
44.08M USD
Avg Volume
46.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.99M | -7.23% |
Net income | -4.81M | 5.45% |
Net profit margin | — | — |
Earnings per share | -0.15 | 37.50% |
EBITDA | -4.97M | 7.56% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.68M | 0.98% |
Total assets | 22.95M | 15.17% |
Total liabilities | 9.70M | 160.54% |
Total equity | 13.25M | — |
Shares outstanding | 27.72M | — |
Price to book | 3.50 | — |
Return on assets | -51.85% | — |
Return on capital | -75.64% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.81M | 5.45% |
Cash from operations | -1.48M | 44.87% |
Cash from investing | -507.15K | -3,748.76% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.01M | 3.10% |
Free cash flow | -207.80K | 78.17% |
About
Founded
2012
Headquarters
Website
Employees
18
